79% of Crohn’s disease patients in remission after early intervention

Giving an immunotherapy drug as soon as possible after diagnosis with Crohn’s disease significantly reduces complications, including the need for surgery by a factor of 10, a clinical study has found. Compared to conventional treatment, which favors de… Continue reading 79% of Crohn’s disease patients in remission after early intervention

“Armored” immune cells make their own medicine to keep fighting cancer

A new form of immunotherapy helps immune cells “armor” themselves against exhaustion by releasing their own medicine to keep them going in the fight against cancer. In a small ongoing trial, 100% of patients have achieved complete remission, and the ne… Continue reading “Armored” immune cells make their own medicine to keep fighting cancer

Cannibalistic cells could provide an edge in future cancer treatments

Following a trail of evidence that started with a study of fruit flies nearly 25 years ago, researchers have found adding a hyperactive form of the protein Rac2 to macrophages, immune cells that eat pathogens, causes them to cannibalize T cells. The no… Continue reading Cannibalistic cells could provide an edge in future cancer treatments

Nanodrones harness natural-born killers to target and destroy cancer

Researchers have made a breakthrough in cancer treatment by harnessing the disease-destroying abilities of the body’s natural killer cells. Their novel nanodrones selectively target a tumor, enabling the killer cells to do what they do best: Suppress c… Continue reading Nanodrones harness natural-born killers to target and destroy cancer

mRNA skin cancer therapy halves risk of death in clinical trial

Moderna has announced the results of a Phase 2b trial investigating its mRNA treatment for skin cancer, and it continues a streak of promising news. When paired with an immunotherapy, the treatment significantly reduced the risks of recurrence, metasta… Continue reading mRNA skin cancer therapy halves risk of death in clinical trial

Once-a-day pill for stubborn cancer delivers a 62.5% positive response

In what has already been tagged as a “game-changer” for cancer treatment, the potent once-a-day tablet known as divarasib has continued to impress at Phase 1b trial stage, outperforming not just current therapies but its previous trial results.Continue… Continue reading Once-a-day pill for stubborn cancer delivers a 62.5% positive response

Fatty acid in beef & dairy found to boost immune cells’ cancer response

A new study has found that trans-vaccenic acid, a fatty acid found in dairy products and the meat of grazing animals, may boost the cancer-killing abilities of the immune system’s T cells. Also found to enhance the effectiveness of immunotherapy, the n… Continue reading Fatty acid in beef & dairy found to boost immune cells’ cancer response

Fatty acid in beef & dairy found to boost immune cells’ cancer response

A new study has found that trans-vaccenic acid, a fatty acid found in dairy products and the meat of grazing animals, may boost the cancer-killing abilities of the immune system’s T cells. Also found to enhance the effectiveness of immunotherapy, the n… Continue reading Fatty acid in beef & dairy found to boost immune cells’ cancer response

Immunotherapy drug proves promising for deadly small cell lung cancer

Researchers have published the results of a clinical trial evaluating the efficacy of an immunotherapy drug in treating a particularly aggressive form of lung cancer. Tarlatamab produced promising results, demonstrating antitumor activity and improving… Continue reading Immunotherapy drug proves promising for deadly small cell lung cancer